Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle Arrest
(−)-Epigallocatechin gallate (EGCG) and curcumin are two naturally derived agents that have been widely investigated worldwide. They exhibit their anti-tumor effects in many types of cancers. In the current study, the effect of the combination of the two agents on non-small cell lung cancer (NSCLC)...
Main Authors: | Wenbin Huang, Xiaoyan Shi, Mingmin Yang, Xuemin Wang, Dong-Hu Zhou, Qing Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/6/12023 |
Similar Items
-
ORAL ADMINISTRATION OF EPIGALLOCATECHIN-3-GALLATE (EGCG) IS A POTENTIAL THERAPEUTIC FOR CISPLATIN-INDUCED HEARING LOSS
by: Borse, Vikrant
Published: (2017) -
Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
by: Aide Negri, et al.
Published: (2018-12-01) -
Insights into the Effect of Curcumin and (–)-Epigallocatechin-3-Gallate on the Aggregation of Aβ(1–40) Monomers by Means of Molecular Dynamics
by: Francesco Tavanti, et al.
Published: (2020-07-01) -
Beneficial Effects of Epigallocatechin-3-<i>O</i>-gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
by: Ryuuta Fukutomi, et al.
Published: (2021-01-01) -
Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
by: Ying Zhong, et al.
Published: (2012-01-01)